Categories
Latest News
- Robin Toft’s WE CAN: The Executive Woman’s Guide to Career Advancement Recognized Within List of 100 Best CEO Books of All Time by BookAuthority07/09/2019 - 8:00 AM
- Toft Group Executive Search Successfully Places Grace Colón, Ph.D. on Board of Directors for CareDx, Inc. in Brisbane, CA07/02/2019 - 3:43 PM
- Toft Group Executive Search Successfully Places Jane Wasman on Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA04/04/2019 - 11:06 AM
Robin Toft’s WE CAN: The Executive Woman’s Guide to Career Advancement Recognized Within List of 100 Best CEO Books of All Time by BookAuthority
/in Press Releases /by ToftgroupSAN FRANCISCO, July 9, 2019 —Toft Group Executive Search, a global life sciences and healthcare executive search firm, today announced that its Chairman and CEO, Robin Toft, has been recognized on BookAuthority’s list of 100 Best CEO Books of All Time for her recently launched professional development book titled WE CAN: The Executive Woman’s Guide to Career Advancement. WE CAN provides valuable insights to empower women to quickly navigate to the career of their dreams.
“I am incredibly honored to have made this prestigious list of best CEO books of all time,” said Robin Toft. “This recognition as one of the best books for professional development highlights my aspiration to empower women in their lives to achieve their dreams.”
The full list of 100 Best CEO Books of all time can be found here, and WE CAN: The Executive Woman’s Guide to Career Advancement can be purchased on Amazon.
As featured on CNN, Forbes and Inc, BookAuthority is the world’s leading site for nonfiction book recommendations for the best books for personal development. BookAuthority uses a proprietary technology to identify and rate the best nonfiction books, using dozens of different signals, including public mentions, recommendations, ratings, sentiment, popularity and sales history. This includes maintaining the most comprehensive collection of book recommendations from domain experts such as Elon Musk, Warren Buffett, Prof. Daniel Kahneman, Sheryl Sandberg, and David Allen.
About WE CAN
Becoming an executive is no easy task. Becoming a female executive is something else altogether. How can the ambitious woman excel, advance, and thrive in seemingly male-dominated industries with thousands of years of history working against her?
Through her own inspiring journey from employee to powerful female executive, Robin Toft shares the wisdom she gleaned at the boardroom table as an executive with over a decade of experience in executive search as Founder and CEO of the award-winning Toft Group. No matter where you are on your executive journey, Robin Toft will move you to action and empower you as a trusted partner through every aspect of your career advancement. Part manual and part memoir, WE CAN provides the confidence, language, and tools to design and realize the career of your dreams. Land the job, make vertical moves, and secure a seat at the boardroom table.
About Robin Toft
Upon founding Toft Group in 2010, Robin essentially launched a second career, following more than two decades as a biotech executive. She was awarded Woman of the Year in San Diego in 2017, in 2018 and 2019 she was a finalist in Ernst & Young’s prestigious Entrepreneur of the Year awards, and she’s been honored as a finalist for San Diego Business Journal’s “Women Who Mean Business” and “Most Admired CEO” awards in multiple years. Robin’s work with Toft Group combines a deep inside knowledge of the life science industry with a passion for building game-changing management teams.
About Toft Group Executive Search
Toft Group is a global life sciences and healthcare executive search firm specializing in diversity and a focus on innovation-driven companies at the intersection of biotech and high tech. Toft Group’s targeted, accurate searches translate into exceptional return-on-investment for clients nationwide, and the team’s extensive networks enable the presentation of more highly qualified and diverse candidates than clients would otherwise see. The firm’s extensive track record has shown its ability to quickly fill highly specialized leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Diego, San Francisco and Boston. For more information, please visit thetoftgroup.com.
Toft Group Executive Search Successfully Places Grace Colón, Ph.D. on Board of Directors for CareDx, Inc. in Brisbane, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Grace Colón, Ph.D, on the Board of Directors for CareDx, Inc. in Brisbane, CA.
Dr. Colón has served as President, Chief Executive Officer and Director of InCarda Therapeutics, Inc., a clinical stage company developing therapeutics for cardiovascular conditions since 2013. In addition to her role at InCarda, she is also Executive Chairman (formerly CEO) of ProterixBio and is on the board of Cocoon Biotech. Previously, she served on the boards of Paradigm Diagnostics and PerceptiMed. She was formerly a partner at New Science Ventures and held various leadership roles at Intrexon Corporation, Gilead Sciences and Affymetrix. Earlier in her career, she was an engagement manager with McKinsey & Co.
Dr. Colón is a native of San Juan, Puerto Rico. She received her Ph.D. in chemical engineering from the Massachusetts Institute of Technology, where she conducted doctoral and post-doctoral research on metabolic engineering of industrial amino acids. She also holds a B.S. degree in chemical engineering from the University of Pennsylvania, where she was a Benjamin Franklin Scholar.
About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum and is the leading provider of genomics-based information for transplant patients.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
Toft Group Executive Search Successfully Places Jane Wasman on Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jane Wasman on the Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA. Ms. Wasman is a strategic leader with over 20 years of experience in the biopharma industry working with both large multinational corporations and privately held start-ups. Her expertise includes strategic development, corporate governance, litigation, commercialization, compliance and government affairs, and operational implementation.
Ms. Wasman currently serves as President, International and General Counsel at Acorda Therapeutics. Prior to joining Acorda, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel. Previously, she was an attorney at two global law firms and Associate Counsel for the U.S. Senate Veterans’ Affairs Committee. Ms. Wasman is Chair of the Board of Sellas Life Sciences and serves on the board of the non-profit NewYorkBIO.
Ms. Wasman graduated magna cum laude from Princeton University, and earned her J.D. from Harvard Law School.
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel’s pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company’s first FDA approved product is TAVALISSE® (fostamatinib disodium hexahydrate), the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. Rigel’s clinical programs include an upcoming Phase 3 study of fostamatinib in autoimmune hemolytic anemia and an ongoing Phase 1 study of R835, a proprietary molecule from its interleukin receptor associated kinase (IRAK) program. In addition, Rigel has product candidates in clinical development with partners BerGenBio ASA, Daiichi Sankyo, Aclaris Therapeutics and AstraZeneca.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.